Northern Trust
OMGA

Northern Trust’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Northern Trust’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-39,706
Closed -$29.6K – 4532
2024
Q4 		$29.6K Hold
39,706
– – ﹤0.01% 4336
2024
Q3 		$48.4K Sell
39,706
-125,068
-76% -$199K ﹤0.01% 4218
2024
Q2 		$341K Sell
164,774
-34,967
-18% -$82.4K ﹤0.01% 3646
2024
Q1 		$729K Buy
199,741
+2,391
+1% +$9.17K ﹤0.01% 3429
2023
Q4 		$594K Sell
197,350
-3,840
-2% -$7.78K ﹤0.01% 3488
2023
Q3 		$433K Sell
201,190
-3,121
-2% -$12.5K ﹤0.01% 3558
2023
Q2 		$1.14M Buy
204,311
+164,939
+419% +$1.29M ﹤0.01% 3305
2023
Q1 		$237K Buy
39,372
+2,422
+7% +$16.9K ﹤0.01% 3785
2022
Q4 		$211K Buy
36,950
+9,766
+36% +$54.8K ﹤0.01% 3845
2022
Q3 		$147K Buy
27,184
+7,301
+37% +$37K ﹤0.01% 3992
2022
Q2 		$76K Sell
19,883
-149,107
-88% -$555K ﹤0.01% 4277
2022
Q1 		$1.05M Buy
168,990
+96,196
+132% +$982K ﹤0.01% 3396
2021
Q4 		$825K Buy
72,794
+6,301
+9% +$120K ﹤0.01% 3614
2021
Q3 		$1.25M Buy
+66,493
New +$1.28M ﹤0.01% 3480

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Northern Trust's OMGA Position: Q1 2025 in Review

Northern Trust sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 39,706 shares — an estimated $29.6K sold.

Northern Trust first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $1.25M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Northern Trust reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Northern Trust sold 39,706 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $29.6K.
  • Northern Trust first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Northern Trust's Omega Therapeutics, Inc. Common Stock position peaked at $1.25M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.